Regencell Bioscience Holdings L (RGC) Financials
RGC Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 12.6 million | 632320 |
2023-06-30 | 12.6 million | 632320 |
2023-03-31 | 12621 | 632 |
2022-12-31 | 15.5 million | 873789 |
RGC Free Cash Flow and Stock based compensation
No data available :(
RGC Net Income
No data available :(
RGC Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 11.6 million | - | - |
2023-06-30 | - | - | 463669 |
2023-03-31 | 11564 | - | - |
2022-12-31 | - | - | - |
RGC Shares Outstanding
RGC Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | - | 231455 | 1041 | 82 |
2023-06-30 | - | - | - | - |
2023-03-31 | - | 115 | 1041 | 82 |
2022-12-31 | - | 1.4 million | 990 | 49 |
RGC Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | - | 769687 |
2023-06-30 | - | - |
2023-03-31 | - | - |
2022-12-31 | - | - |
RGC
Price: $5.35
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.45 USD
P/E Ratio: -17.78
Exchange: NCM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 700
Ebitda: 521.8 millionMarket Capitalization: 48.3 million
Average Dividend Frequency: 4